Announcements Trials
Browse Landscape

Status

Completed 1387Terminated 339Unknown 217Recruiting 179Withdrawn 96Active not recruiting 84Not yet recruiting 37Suspended 7No longer available 6Enrolling by invitation 4Available 2Approved for marketing 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 4Hematologic Neoplasms 3Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Immunologic Deficiency Syndromes 2Thalassemia 1Recurrence 1Multiple Myeloma 1Metabolic Diseases 1Mastocytosis, Systemic 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Leukemia, Plasma Cell 1Leukemia, Mast-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Burkitt Lymphoma 1Bone Marrow Failure Disorders 1Anemia, Sickle Cell 1Anemia, Aplastic 1Amyloidosis 1Adrenoleukodystrophy 1

Interventions

tisagenlecleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Available × Leukemia × Other hematologic neoplasm × Clear all
NCT03601442 2026-04-23

Managed Access Programs for CTL019, Tisagenlecleucel

Novartis

Available
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT03145545 2025-05-22

Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

Children's Hospital of Philadelphia

Available
Other hematologic neoplasm

Bone Marrow Failure Disorders, Immunologic Deficiency Syndromes, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡